Evidence map›Paper›PMID 33706787›Full record

ArticleBMC biology2021

Divergent CPEB prion-like domains reveal different assembly mechanisms for a generic amyloid-like fold.

Rubén Hervás, María Del Carmen Fernández-Ramírez, Albert Galera-Prat, Mari Suzuki, Yoshitaka Nagai, Marta Bruix, Margarita Menéndez, Douglas V Laurents, Mariano Carrión-Vázquez

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. QBP1 Peptide as a Potential Anti-Amyloidogenic Therapy for Type 2 Diabetes: An In Vitro Study.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Conformational inhibitors of protein aggregation.Current opinion in structural biology · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Rubén Hervás *Instituto Cajal, IC-CSIC, Avda. Doctor Arce 37, E-28002, Madrid, Spain. ruhm@hku.hk.
María Del Carmen Fernández-Ramírez *Instituto Cajal, IC-CSIC, Avda. Doctor Arce 37, E-28002, Madrid, Spain.
Albert Galera-PratInstituto Cajal, IC-CSIC, Avda. Doctor Arce 37, E-28002, Madrid, Spain.
Mari SuzukiDepartment of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
Yoshitaka NagaiDepartment of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
Marta BruixInstituto de Química-Física Rocasolano, IQFR-CSIC, Serrano 119, E-28006, Madrid, Spain.
Margarita MenéndezInstituto de Química-Física Rocasolano, IQFR-CSIC, Serrano 119, E-28006, Madrid, Spain.
Douglas V LaurentsInstituto de Química-Física Rocasolano, IQFR-CSIC, Serrano 119, E-28006, Madrid, Spain.
Mariano Carrión-VázquezInstituto Cajal, IC-CSIC, Avda. Doctor Arce 37, E-28002, Madrid, Spain. mcarrion@cajal.csic.es.ORCID 0000-0001-7319-406X
Instituto Cajal · ESInstituto de Química Física Blas Cabrera · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESKindai University Hospital · JPTokyo Metropolitan Institute of Medical Science · JP

Funding

Ministerio de Economía, Industria y Competitividad, Gobierno de España BFU2015-70072-RMinisterio de Economía, Industria y Competitividad, Gobierno de España SAF2016-76678-C2-2-RMinisterio de Economía y Competitividad SAF2013-49179-C2-1-RMinisterio de Economía y Competitividad SAF2013-49179-C2-2-RMinisterio de Economía y Competitividad SAF2016-76678-C2-1-R
6 · The paper itself

Abstract

backgroundAmyloids are ordered, insoluble protein aggregates, characterized by a cross-β sheet quaternary structure in which molecules in a β-strand conformation are stacked along the filament axis via intermolecular interactions. While amyloids are typically associated with pathological conditions, functional amyloids have also been identified and are present in a wide variety of organisms ranging from bacteria to humans. The cytoplasmic polyadenylation element-binding (CPEB) prion-like protein is an mRNA-binding translation regulator, whose neuronal isoforms undergo activity-dependent aggregation, a process that has emerged as a plausible biochemical substrate for memory maintenance. CPEB aggregation is driven by prion-like domains (PLD) that are divergent in sequence across species, and it remains unknown whether such divergent PLDs follow a similar aggregating assembly pathway. Here, we describe the amyloid-like features of the neuronal Aplysia CPEB (ApCPEB) PLD and compare them to those of the Drosophila ortholog, Orb2 PLD.

resultsUsing in vitro single-molecule and bulk biophysical methods, we find transient oligomers and mature amyloid-like filaments that suggest similarities in the late stages of the assembly pathway for both ApCPEB and Orb2 PLDs. However, while prior to aggregation the Orb2 PLD monomer remains mainly as a random coil in solution, ApCPEB PLD adopts a diversity of conformations comprising α-helical structures that evolve to coiled-coil species, indicating structural differences at the beginning of their amyloid assembly pathways.

conclusionOur results indicate that divergent PLDs of CPEB proteins from different species retain the ability to form a generic amyloid-like fold through different assembly mechanisms.

Indexed as

AmyloidAnimalsAplysiaPolyadenylationPrionsAmyloidPrionsCoiled coilCytoplasmic polyadenylation element binding protein (CPEB)Functional amyloidsMemory persistencePrion-like protein

Identifiers

PMID33706787
PMCPMC7953810
OpenAlexW3134553760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.